NADAC acquisition cost data for FEMRING 0.05 MG/DAY VAG RING. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 72495020105 | $664.72 | 2023-01-01 | Rx |
Generic: Estradiol Acetate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $3.5M | 7,183 | 3,049 | $482.90 |
| 2020 | $5.1M | 9,465 | 3,027 | $533.18 |
| 2021 | $5.6M | 9,156 | 2,941 | $602.40 |
| 2022 | $6.0M | 8,899 | 2,878 | $667.41 |
| 2023 | $6.5M | 8,715 | 2,894 | $735.60 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $1.2M | 1,659 | 525 |
| Florida | $474.8K | 615 | 209 |
| Texas | $342.1K | 461 | 159 |
| Michigan | $340.8K | 485 | 156 |
| North Carolina | $263.1K | 347 | 123 |
| New York | $254.0K | 345 | 121 |
| Washington | $246.7K | 311 | 108 |
| Colorado | $216.1K | 295 | 102 |
| Georgia | $211.5K | 280 | 95 |
| Ohio | $198.7K | 267 | 88 |
| Oregon | $198.3K | 264 | 86 |
| Illinois | $194.9K | 261 | 86 |
| Arizona | $150.1K | 190 | 72 |
| Oklahoma | $146.6K | 190 | 61 |
| Louisiana | $139.6K | 185 | 63 |
| Virginia | $137.0K | 176 | 60 |
| Pennsylvania | $124.5K | 169 | 60 |
| Tennessee | $123.0K | 165 | 58 |
| Wisconsin | $116.8K | 159 | 59 |
| Connecticut | $112.4K | 149 | 54 |
| Massachusetts | $109.1K | 152 | 48 |
| South Carolina | $98.0K | 134 | 44 |
| Maryland | $92.5K | 128 | 44 |
| Alabama | $89.6K | 116 | 39 |
| Indiana | $87.2K | 116 | 41 |
| New Jersey | $79.2K | 113 | 36 |
| Missouri | $78.4K | 102 | 42 |
| Kentucky | $77.3K | 95 | 31 |
| Nevada | $61.7K | 83 | 29 |
| Utah | $56.6K | 78 | 26 |
| Minnesota | $53.0K | 69 | 22 |
| Nebraska | $51.0K | 66 | 23 |
| New Mexico | $49.6K | 65 | 21 |
| Kansas | $48.0K | 64 | 24 |
| Idaho | $30.6K | 42 | 15 |
| Maine | $26.8K | 36 | 12 |
| New Hampshire | $23.4K | 26 | 11 |
| West Virginia | $23.3K | 30 | 13 |
| Iowa | $18.6K | 25 | 11 |
| District of Columbia | $16.8K | 22 | N/A |
| Montana | $16.7K | 22 | N/A |
| Mississippi | $16.5K | 20 | N/A |
| Arkansas | $16.3K | 21 | N/A |
| Rhode Island | $14.5K | 20 | N/A |
| Delaware | $13.6K | 20 | N/A |
| Vermont | $13.5K | 19 | N/A |
| Hawaii | $12.1K | 17 | N/A |
| Alaska | $11.6K | 15 | N/A |
| North Dakota | $8.0K | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.